Lipid-Based Nanocarriers: Bridging Diagnosis and Cancer Therapy.

MLA

Giordano, Alessandra, et al. “Lipid-Based Nanocarriers: Bridging Diagnosis and Cancer Therapy.” Pharmaceutics, vol. 16, no. 9, Sept. 2024, p. 1158. EBSCOhost, https://doi.org/10.3390/pharmaceutics16091158.

APA

Giordano, A., Provenza, A. C., Reverchon, G., Baldino, L., & Reverchon, E. (2024). Lipid-Based Nanocarriers: Bridging Diagnosis and Cancer Therapy. Pharmaceutics, 16(9), 1158. https://doi.org/10.3390/pharmaceutics16091158

Chicago

Giordano, Alessandra, Anna Chiara Provenza, Giorgio Reverchon, Lucia Baldino, and Ernesto Reverchon. 2024. “Lipid-Based Nanocarriers: Bridging Diagnosis and Cancer Therapy.” Pharmaceutics 16 (9): 1158. doi:10.3390/pharmaceutics16091158.